Skip to content

Randomized study to decide the post-operative treatment in ampullary carcinoma

A phase 2 randomized study of adjuvant chemotherapy versus chemotherapy followed by chemoradiation in radically resected ampullary cancers - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093550
Enrollment
60
Registered
2025-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C241- Malignant neoplasm of ampulla of Vater

Interventions

Intervention1: Adjuvant chemotherapy followed by chemoradiation: Intestinal subtype: 3 cycles CAPOX followed by Concurrent chemoradiation (50.4Gy) with capecitabine (daily 1650mg/m2) followed by 3 mo

Sponsors

Sanjay Gandhi Post Graduate Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who have undergone radical resection of ampullary carcinoma (R0). Stage 2 and 3 Have an Karnofsky performance status of 80-90. Must be able to start treatment within 6 weeks of surgery Have normal organ and marrow function. No evidence of infection Weight loss not exceeding 10% in the preceding 3 months

Exclusion criteria

Exclusion criteria: 1. R1 resection 2. Non-radical surgery 3. Node negative disease 4. Serious co-existing medical condition likely to interfere with protocol treatment, including a potential serious infection 5. Evidence of significant clinical disorder or laboratory finding that makes it undesirable for the patient to participate in the trial

Design outcomes

Primary

MeasureTime frame
To compare the disease-free survival of patients in both armsTimepoint: 1 year, 2 year

Secondary

MeasureTime frame
To compare the overall survival of patients in both arms. To compare acute toxicity between the 2 arms. To compare the QOL (FACT QOL) in both arms.Timepoint: 1-yr, 2-yr

Countries

India

Contacts

Public ContactSushma Agrawal

Sanjay Gandhi Post Graduate Institute of Medical Sciences

sushmaagrawal@yahoo.co.uk09415408949

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026